The grades of 10 Medical Devices stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an “A” (“strong buy”) or “B” overall (“buy”).
This week, Derma Sciences (NASDAQ:DSCI) is making solid headway. The company’s rating improves to an A (“strong buy”) from last week’s B (“buy”) rating. Derma Sciences markets and sells a range of skin care, wound management, and specialty securement devices. In Portfolio Grader’s specific subcategories of Earnings Revisions and Sales Growth, DSCI also gets A’s. Shares of DSCI have increased 13% over the past month, better than the 5.3% increase the Nasdaq has seen over the same period of time. For more information, get Portfolio Grader’s complete analysis of DSCI stock.
The rating of Winner Medical Group (NASDAQ:WWIN) moves up this week, rising from a B to an A. Winner Medical Group engages in the research, development, manufacture, and marketing of cotton-base medical dressings and medical disposables. For more information, get Portfolio Grader’s complete analysis of WWIN stock.
This week, Analogic (NASDAQ:ALOG) is showing significant improvement as the company’s rating hops from a C (“hold”) to a B (“buy”). Analogic is a technology company that designs and manufactures medical imaging and security systems and subsystems that are used primarily in the healthcare and airport security markets. Investors seem to agree with the upgraded status of the stock, and have pushed the stock up 6% over the past month. For more information, get Portfolio Grader’s complete analysis of ALOG stock.
Cutera’s (NASDAQ:CUTR) ratings are looking better this week, moving up to a B from last week’s C. Cutera is a global provider of laser and other light-based aesthetic systems for practitioners worldwide. Investors have pushed the stock price up 20.6% over the past month. For more information, get Portfolio Grader’s complete analysis of CUTR stock.
This week, HeartWare International’s (NASDAQ:HTWR) ratings are up from a C last week to a B. HeartWare International is developing a range of implantable mechanical circulatory assist devices or heart pumps, used for the treatment of congestive heart failure. Wall Street has pushed the stock higher by 15.1% over the past month. For more information, get Portfolio Grader’s complete analysis of HTWR stock.
Medtronic Inc. (NYSE:MDT) improves from a C to a B rating this week. Medtronic develops therapeutic and diagnostic medical products. Investors seem to agree with the upgraded status of the stock, and have pushed the stock up 12.4% over the past month. For more information, get Portfolio Grader’s complete analysis of MDT stock.
This week, NuVasive (NASDAQ:NUVA) pushes up from a C to a B rating. Nuvasive designs, develops, and markets products for the surgical treatment of spine disorders. Wall Street seems to agree with the upgrade and has propelled the stock up 17.5% over the past month. For more information, get Portfolio Grader’s complete analysis of NUVA stock.
This is a strong week for Intuitive Surgical (NASDAQ:ISRG). The company’s rating climbs to B from the previous week’s C. Intuitive Surgical designs, manufactures, and markets da Vinci Surgical Systems, EndoWrist instruments, and surgical accessories. Wall Street has pushed the stock higher by 19.3% over the past month. For more information, get Portfolio Grader’s complete analysis of ISRG stock.
Meridian Bioscience (NASDAQ:VIVO) shows solid improvement this week. The company’s rating rises from a C to a B. Meridian Bioscience manufactures diagnostic test kits, bulk antigens, antibodies and bioresearch reagents used by researchers and other diagnostic manufacturers. For more information, get Portfolio Grader’s complete analysis of VIVO stock.
EnteroMedics (NASDAQ:ETRM) earns a B this week, jumping up from last week’s grade of C. EnteroMedics is a development stage medical device company focused on the design and development of devices that use neuroblocking technology to treat obesity and other gastrointestinal disorders. Wall Street seems to agree with the upgrade and has propelled the stock up 8.9% over the past month. For more information, get Portfolio Grader’s complete analysis of ETRM stock.
Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.
